Catalyst Wire Dossier Catalyst Wire Dossier

KHAPZORY

LEVOLEUCOVORIN · Acrotech Biopharma Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KHAPZORY, covering 2018-10-19 to 2020-03-03. Get the full timeline:

Most recent: FDA Approved: KHAPZORY — Supplemental Application (Acrotech Biopharma Inc)

See pricing